drugset / Trial / NCT01296503
Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma
RandomizedParallel-groupOpen-labelTreatment
Summary
This multicenter, prospective, randomized trial was designed to evaluate the role of thalidomide with or without dexamethasone as a maintenance therapy for multiple myeloma patients after a single autologous stem cell transplantation.
Timeline
- Start
- 2003-10
- Primary completion
- 2008-07
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thalidomide | Other / unclassified | 200 mg | Oral |
| Comparator | Dexamethasone | Small molecule | 40 mg | Oral |